ロード中...
Phase I Trial of Weekly Cabazitaxel with Concurrent Intensity Modulated Radiation and Androgen Deprivation Therapy for the Treatment of High-Risk Prostate Cancer
PURPOSE: Cabazitaxel has been demonstrated to improve the overall survival for men with metastatic castrate-resistant prostate cancer. The purpose of this study was to determine the maximum tolerated dose for concurrent cabazitaxel with androgen deprivation and intensity modulated radiation therapy...
保存先:
| 出版年: | Int J Radiat Oncol Biol Phys |
|---|---|
| 主要な著者: | , , , , , , , , , , , |
| フォーマット: | Artigo |
| 言語: | Inglês |
| 出版事項: |
2020
|
| 主題: | |
| オンライン･アクセス: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8186272/ https://ncbi.nlm.nih.gov/pubmed/32029346 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ijrobp.2019.11.418 |
| タグ: |
タグ追加
タグなし, このレコードへの初めてのタグを付けませんか!
|